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ABSTRACT
Sarcoidosis is a systemic granulomatous disorder of unknown cause that occurs in both men and women of all races. It typically
presents in patients after 20 years of age. Sarcoidosis most frequently involves the lung, but up to 30 percent of patients
present with extra-thoracic manifestations. It can involve multiple organs to a variable extent and degree. In areas, where tuber-
culosis is endemic, the diagnosis of sarcoidosis may be overlooked and misdiagnosed because of clinical and radiographic
resemblance. Herein, we present a case of a middle-aged man who visited multiple physicians with constitutional symptoms
and was treated symptomatically but did not improve. He later developed skin lesions which were biopsied and led to correct
diagnosis of sarcoidosis. Hence, a clinician should be aware of all the spectrums of presentations of rare diseases like sarcoi-
dosis and always keep it as a differential when treating common diseases like tuberculosis.
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INTRODUCTION
Sarcoidosis  is  a  multisystemic  disease  of  unknown  etiology
affecting people of all ages and races.1 The lungs are the most
frequent organs involved; however, extrapulmonary sites like
skin, eyes, liver, spleen, and bone are also involved. The basis of
diagnosis  is  non-caseating  granulomas  found  on  histo-
pathology. However, some cases do not present with typical
symptoms specific to an organ and; hence, can make the diag-
nosis challenging. Certain constitutional symptoms like fever,
fatigue, and lethargy can be an initial manifestation of sarcoi-
dosis and can easily lead to alternate diagnosis especially in a
country where tuberculosis is endemic. Hence as a clinician,
one should be aware of all the spectra of sarcoidosis so that accu-
rate diagnosis and appropriate management can be facilitated.
CASE REPORT
A 42-year  old  man,  a  known case  of  non-insulin  dependent
diabetes mellitus, presented to the outpatient clinic with the
complaint of generalised weakness, fatigue on moderate exer-
tion, pain in limbs and low-grade undocumented fever since one
year. He visited multiple physicians and multiple clinics with
these complains and received symptomatic treatment, but the
symptoms did not improve much.
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Fatigue  and  weakness  were  the  predominant  symptoms  that
persisted despite being advised multiple medications. Later, he
started developing erythematous plaques on skin predominantly
on the left arm but later involving right leg and axilla.
On examination, patient was vitally and hemodynamically stable.
There was no hypotension throughout the clinical course. Due to
the progressive nature of the skin lesions, dermatology opinion
was  taken  and  incisional  skin  biopsy  was  planned  and  done
uneventfully.  It  reported  chronic  granulomatous  inflammation
without necrosis representing nodular sarcoidosis. Subsequently,
the patient was referred to pulmonary outpatient clinic and his
laboratory and radiological workup was done to see the involve-
ment of other organs.
Relevant laboratory workup showed Erythrocyte Sedimentation
Rate (ESR) to be 23 mm/1st  hour (normal:  0-15).  Angiotensin
Converting Enzyme (ACE) levels were >150 U/L. Serum calcium
was 9.9 mg/dl (normal: 8.6-10.2 mg/dl). High resolution computed
tomography (HRCT) scan was done which showed infiltrates in
bilateral lung fields with bilateral hilar and mediastinal lympha-
denopathy. Pulmonary function tests showed forced vital capacity
(FVC)  of  4.11(95%),  forced  expiratory  volume  in  one  second
(FEV1) was 3.46 (98%) with FEV1/FVC ratio of 84%.
The patient was then started on systemic and topical steroids,
after  which  his  symptoms improved.  Gradually,  steroids  were
tapered to a maintenance dose. He later became clinically stable
and is on a regular outpatient clinic follow-up.
DISCUSSION
Sarcoidosis is a multi-systemic disease with worldwide distribu-
tion;  and  it  affects  people  of  all  races.  Sarcoidosis  usually
involves the lungs but extra-thoracic manifestations of sarcoi-
dosis are present in approximately 30% of cases.2 Skin lesions
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are one of the most common extra-thoracic manifestations of
sarcoidosis.3 Cutaneous sarcoidosis in black South Africans was
studied by Jacyk.4 A total of 54 patients were studied, of which 45
were  women  and  nine  men.  The  presenting  features  in  all
patients were skin lesions; however, in 40 patients, systemic
sarcoidosis  was  found  on  further  clinical  workup.4  Hence,
patients do present with skin manifestations as the presenting
feature of sarcoidosis; but on further evaluation, the majority
tend to have systemic involvement with the lung being the most
commonly involved organ. In the clinical update of sarcoidosis
by Costabel, different modes of clinical presentation have been
defined.5 These include fever, weight loss, drenching sweats,
and fatigue. The author classified sarcoidosis on the basis of the
onset of symptoms into two subsets. The first one, called acute
sarcoidosis, with abrupt onset more frequent in Caucasians,
may present as Lofgren’s syndrome, which is characterised by
bilateral hilar adenopathy, ankle arthritis, erythema nodosum,
and  frequently  constitutional  symptoms  including  fever,
myalgia, malaise, and weight loss. The prognosis in this subset
is good. The second one, labelled as chronic sarcoidosis, has an
insidious  onset.  Organ-related  symptoms,  often  related  to
pulmonary infiltration, such as cough and dyspnoea, predomi-
nate;  whereas,  constitutional  symptoms  are  rarer  than  the
acute form. Therefore, sarcoidosis should always be considered
as one of the differential diagnoses in patients with fever of
unknown origin.5,6 Fatigue has been underestimated in sarcoid
patients and ironically, it is one of the most frequently reported
symptoms. De Kleijn  et al in their systemic review identified
fatigue as one of the most prominent symptoms affecting the
quality of life in patients with sarcoidosis.7 In an epidemiological
study done in the Dutch population, the clinical presentation of
sarcoidosis  was  assessed  and  it  was  found  that  the  most
frequently reported symptom was fatigue (71%), followed by
dyspnoea (70%), and arthralgia (52%).8 Fleischer et al studied
the factors leading to fatigue in sarcoidosis and found that asso-
ciated diseases like pulmonary hypertension and sleep apnoea
had the greatest impact in elevating fatigue. Moreover, extra-
thoracic sarcoidosis involving muscles, bones, and nerves is
most strongly associated with fatigue. The association between
the duration of prednisolone therapy and fatigue was weak.9
Spruit   et  al  reported  that  patients  with  sarcoidosis  have
increased skeletal muscle weakness resulting in fatigue. This
often leads to reduced health status and exercise tolerance.10
Our patient had constitutional symptoms including low-grade
fever, fatigue, and arthralgia which masked and delayed the
diagnosis for a year. Although sarcoidosis is not a difficult diag-
nosis to establish; however, in Sub-continent, where tubercu-
losis is endemic, physicians tend to treat it as tuberculosis first,
owing to clinical and radiological similarities. Guleria et al dis-
cussed the same fact, that in India, there is a strong likelihood
that sarcoidosis is misdiagnosed as tuberculosis owing to high
prevalence and clinical and radiological resemblance.11 Sarcoi-
dosis mimics a wide variety of diseases. The natural history of
sarcoidosis is highly variable. In some instances, spontaneous
remission can occur while the remaining cases have chronic
progressive disease.12 Hence as a clinician, one should always
suspect sarcoidosis in a patient with progressive constitutional
symptoms. Timely diagnosis can facilitate the management of
the disease in the early stages when the prognosis is good.
When the disease progresses, both the management and the
prognosis are adversely affected. Although this presentation is
not rare, the vagueness of the symptoms can always deceive a
clinician towards alternative diagnoses.
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